Neurology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Figures Only
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Correspondence:
Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when Correspondence are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Ladogana, A.
Right arrow Articles by Pocchiari, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ladogana, A.
Right arrow Articles by Pocchiari, M.
Related Collections
Right arrow Prion
Right arrow All Cognitive Disorders/Dementia
Right arrow All epidemiology
Right arrow Incidence studies
Right arrowRelated Article
NEUROLOGY 2005;64:1592-1597
© 2005 American Academy of Neurology

High incidence of genetic human transmissible spongiform encephalopathies in Italy

A. Ladogana, MD, M. Puopolo, Dstat, A. Poleggi, PhD, S. Almonti, MD, V. Mellina, MD, M. Equestre and M. Pocchiari, MD

From the Department of Cell Biology and Neurosciences, Istituto Superiore di Sanità, Rome, Italy.

Address correspondence and reprint requests to Dr. Maurizio Pocchiari, Department of Cell Biology and Neurosciences, Istituto Superiore di Sanità, Rome, Italy, Viale Regina Elena 299, 00161 Rome, Italy; e-mail: pocchia{at}iss.it

Objective: To assess the incidence and mortality rates of genetic transmissible spongiform encephalopathy (TSE) diseases in Italy.

Methods: The authors have sequenced the prion protein gene (PRNP) in 643 patients referred to the Italian Registry of Creutzfeldt-Jakob disease (CJD) and related disorders between 1993 and 2002. Crude age- and sex-specific incidence and mortality rates were calculated. Differences in morbidity from genetic TSE diseases in the 20 Italian regions were assessed by the standardized morbidity ratio (SMR).

Results: A total of 130 cases were classified as genetic TSE diseases with a mean yearly incidence rate of 0.28 cases per million people. Genetic TSE diseases represent 17.7% of all TSE diseases, including sporadic, iatrogenic, and variant CJD. The most frequent mutation was the V210I (n = 54), and the second most common the E200K (n = 42). Mortality rates for genetic TSE diseases did not increase in any of the age groups under examination over the 10 years of surveillance. The analysis of regional distribution of genetic cases by place of birth revealed that in Campania and Calabria regions the number of genetic TSE cases was higher than in other regions.

Conclusions: In Italy the incidence of genetic transmissible spongiform encephalopathy (TSE) diseases is the second highest among European countries. Genetic analysis is important for a correct classification of patients with TSE.

Supported by the Istituto Superiore di Sanità, Ministry of Health, Italy.

Received September 15, 2004. Accepted in final form January 24, 2005.


Related Article

May 10 Highlights
Neurology 2005 64: 1492-1493. [Full Text] [PDF]



This article has been cited by other articles:


Home page
 BrainHome page
S. J. Collins, P. Sanchez-Juan, C. L. Masters, G. M. Klug, C. van Duijn, A. Poleggi, M. Pocchiari, S. Almonti, N. Cuadrado-Corrales, J. de Pedro-Cuesta, et al.
Determinants of diagnostic investigation sensitivities across the clinical spectrum of sporadic Creutzfeldt-Jakob disease
Brain, September 1, 2006; 129(9): 2278 - 2287.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2005 by AAN Enterprises, Inc.